| 1152311-94-8 |
|
1H-Indole-2-ethanol, 5-amino-1-[[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl]-6-fluoro-β,β-dimethyl- |
C18H25FN2O3 |
| 1152313-76-2 |
(4S)-2-[2-(二苯基膦)苯基]-4,5-二氢-5,5-二甲基-4-(1-甲基乙基)-噁唑 |
(4S)-2-[2-(diphenylphosphino)phenyl]-4,5-dihydro-5,5-diMethyl-4-(1-Methylethyl)-oxazole |
C26H28NOP |
| 115233-93-7 |
(R)-DMT-glycidol-A(Bz) |
(R)-DMT-glycidol-A(Bz) |
C36H33N5O5 |
| 1152333-96-4 |
|
2H-1-Benzopyran-3,4,4a,6,7(5H)-pentol, hexahydro-2-(hydroxymethyl)-, (2R,3S,4S,4aS,6R,7S,8aS) |
C10H18O7 |
| 115234-25-8 |
Eugenol Impurity 25 |
Eugenol Impurity 25 |
C10H12O4S |
| 115235-63-7 |
|
2-Proenoic acid, isooctyl ester, polymer with 1-ethenyl-2-pyrrolidinone and 2-propenamide |
C20H34N2O4 |
| 115236-57-2 |
|
DFLNNH |
C52H88N2O39 |
| 115236-58-3 |
MONOFUCOSYL-半乳-N-己糖 Ⅳ |
BETA-GAL-[1->3]-BETA-GLCNAC-[1->3]-BETA-GAL-[1-4][ALPHA-FUC-(1->3)]-BETA-GLCNAC-[1->3]-BETA-GAL-[1->4]-GLC |
C46H78N2O35 |
| 115236-65-2 |
Vancomycin hexapeptide |
Vancomycin hexapeptide |
C59H62Cl2N8O23 |
| 115236-67-4 |
|
4(3H)-Quinazolinone, 6-bromo-2-(4-methylphenyl) |
C15H11BrN2O |
| 115236-84-5 |
|
β-D-Glucopyranosyl fluoride, 2,3,4-triacetate |
C12H17FO8 |
| 1152367-80-0 |
3-S-1,3-二甲基哌嗪 |
(3S)-1,3-dimethylpiperazine(SALTDATA: FREE) |
C6H14N2 |
| 1152367-83-3 |
(3R)-4,4-diMethyl-3-Pyrrolidinol |
|
C6H13NO |
| 1152367-84-4 |
(R)-N,N-dimethyl-1-(morpholin-3-yl)methanamine |
|
C7H16N2O |
| 1152367-85-5 |
(2S,5R)-1,2,5-三甲基哌嗪 |
(2S,5R)-1,2,5-trimethylpiperazine |
C7H16N2 |
| 1152367-87-7 |
|
Morpholine, 4-(3-methyl-3-azetidinyl) |
C8H16N2O |
| 1152367-90-2 |
|
Piperazine, 1,2,3-trimethyl-, (2R,3S) |
C7H16N2 |
| 1152368-00-7 |
(2R,5R)-1,2,5-trimethylpiperazine |
(2R,5R)-1,2,5-trimethylpiperazine |
C7 H16 N2 |
| 115238-58-9 |
(3S,4AS,8AS)-十氢-3-异喹啉羧酸 |
DECANHYDROISOQUINOLINE-3-CARBOXYLIC ACID |
C10H17NO2 |
| 115238-59-0 |
(3S,4AS,8AS)-2-(叔丁氧羰基)十氢异喹啉-3-羧酸 |
2,3(1H)-Isoquinolinedicarboxylic acid, octahydro-, 2-(1,1-diMethylethyl) ester, (3S,4aS,8aS) |
C15H25NO4 |
| 115239-36-6 |
|
Propanamide, N-[1-[[4-(aminoiminomethyl)phenyl]methyl]-2-oxo-2-(1-piperidinyl)ethyl]-2-[(2-naphthalenylsulfonyl)amino] |
C28H33N5O4S |
| 115239-41-3 |
3-甲基-2-(萘-2-磺酰胺)丁酸 |
N-(naphthalen-2-ylsulfonyl)valine |
C15H17NO4S |
| 115240-91-0 |
2-(羟基对甲苯甲基)-丙烯酸甲酯 |
2-(HYDROXY-P-TOLYL-METHYL)-ACRYLIC ACID METHYL ESTER |
C12H14O3 |
| 115240-92-1 |
2-(羟基(4-甲氧基苯基)甲基)丙烯酸甲酯 |
Benzenepropanoic acid, β-hydroxy-4-methoxy-α-methylene-, methyl ester |
C12H14O4 |
| 115241-16-2 |
|
L-Sorbose, 6-deoxy-6-(formylamino) |
C7H13NO6 |
| 115241-77-5 |
|
2-[2,4-Bis(1,1-dimethylpropyl)phenoxy]-N,N-diethylacetamide |
C22H37NO2 |
| 115241-94-6 |
(喹啉-8-磺酰基氨基)乙酸 |
(QUINOLINE-8-SULFONYLAMINO)-ACETIC ACID |
C11H10N2O4S |
| 1152412-98-0 |
N,1-Dimethyl-L-tryptophan |
|
C13H16N2O2 |
| 115242-45-0 |
|
2H-1,2,5-Thiadiazino[5,6-a]benzimidazole,2-butyl-3,4-dihydro-7-nitro-, 1,1-dioxide |
C13H16N4O4S |
| 1152425-66-5 |
Luseogliflozin (hydrate) |
|
C23H32O7S |
| 1152427-91-2 |
环氧乙基硼酸甲基亚氨基二乙酸酯 |
Oxiranyl boronic acid MIDA ester |
C7H10BNO5 |
| 1152427-93-4 |
反式-2-苯基乙烯基硼酸甲基亚氨基二乙酸酯 |
trans-2-Phenylvinylboronic acid MIDA ester |
C13H14BNO4 |
| 1152427-99-0 |
反式-(2-环己基乙烯基)硼酸甲基亚氨基二乙酸酯 |
trans-(2-Cyclohexylvinyl)boronic acid MIDA ester |
C13H20BNO4 |
| 1152428-38-0 |
|
Quinazoline, 2-chloro-1,4-dihydro-4,4-dimethyl |
C10H11ClN2 |
| 1152428-42-6 |
|
β-Alanine, N-(3-bromophenyl)-N-[(4-methylphenyl)sulfonyl]- |
C16H16BrNO4S |
| 1152428-59-5 |
tert-Butyl (6-nitropyridin-2-yl)carbaMate |
tert-Butyl (6-nitropyridin-2-yl)carbaMate |
C10H13N3O4 |
| 1152430-21-1 |
1152430-21-1 |
4-BOC-AMino-1-(isopentanoyl)piperidine |
C15H28N2O3 |
| 1152430-26-6 |
1-环丙基羰基-(4-BOC氨基)哌啶 |
4-Boc-Amino-1-cyclopropanecarbonylpiperidine |
C14H24N2O3 |
| 1152430-72-2 |
6-chloro-5-({[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl}acetyl)-1,3-dihydro-2H-indol-2-one |
|
C18H11ClFN3O3S |
| 1152430-80-2 |
|
6-(3,4-dimethoxyphenyl)-3-[(2-pyridin-2-ylbenzimidazol-1-yl)methyl]-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole |
C24H19N7O2S |
| 1152430-91-5 |
|
6-(4-methylphenyl)-3-(2-phenylethyl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole |
C18H16N4S |
| 1152431-76-9 |
5-甲基-2,1,3-苯并恶二唑-4-磺酰氯 |
5-methyl-2,1,3-benzoxadiazole-4-sulfonyl chloride(SALTDATA: FREE) |
C7H5ClN2O3S |
| 1152432-71-7 |
N-cyclopentyl-2-(4,6-dimethylpyrimidin-2-yl)sulfanyl-2-phenylacetamide |
|
C19 H23 N3 O S |
| 1152438-32-8 |
(11BR)-2,6-双[4-(1,1-二甲基乙基)-2,6-双(1-甲基乙基)苯基]-4-羟基-4-氧化物-4Λ5-萘并[2,1-D]:1',2'-F][1,3,2]二氧杂膦 |
(11bR)-2,6-bis[4-(1,1-dimethylethyl)-2,6-bis(1-methylethyl)phenyl]-4-hydroxy-4-oxide-4λ5-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin |
C52H61O4P |
| 1152439-73-0 |
2,2-DiMethyl-5-[(2,4,5-trifluorophenyl)acetyl]-1,3-dioxane-4,6-dione |
|
C14H11F3O5 |
| 1152439-79-6 |
IMidazo[1,5-a]pyrazin-1-aMine, 5,6,7,8-tetrahydro-3-(trifluoroMethyl)- |
IMidazo[1,5-a]pyrazin-1-aMine, 5,6,7,8-tetrahydro-3-(trifluoroMethyl) |
C7H9F3N4 |
| 1152439-93-4 |
|
1-methyl-3-(trifluoromethyl)imidazo[1,5-a]pyrazine |
C8H6F3N3 |
| 1152440-23-7 |
洛索洛芬杂质40 |
Loxoprofen Impurity 40 |
C19H24O5 |
| 1152441-29-6 |
3-(4,5-二甲基-1,3,2-二硼戊环-2-基)-4-氟苯胺 |
4-Fluoro-3-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)aniline |
C12H17BFNO2 |
| 1152441-87-6 |
(-)-芝麻素22'-二醇 |
(-)-Sesamin 2,2'-diol |
C20H18O8 |
中文
